Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
30.9M
-
Number of holders
-
578
-
Total 13F shares, excl. options
-
25.3M
-
Shares change
-
+241K
-
Total reported value, excl. options
-
$8.42B
-
Value change
-
+$79M
-
Put/Call ratio
-
0.93
-
Number of buys
-
279
-
Number of sells
-
-286
-
Price
-
$332.23
Significant Holders of Medpace Holdings, Inc. - Common Stock (MEDP) as of Q4 2024
672 filings reported holding MEDP - Medpace Holdings, Inc. - Common Stock as of Q4 2024.
Medpace Holdings, Inc. - Common Stock (MEDP) has 578 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.3M shares
of 30.9M outstanding shares and own 82.08% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (2.73M shares), VANGUARD GROUP INC (2.57M shares), Invesco Ltd. (1.08M shares), WASATCH ADVISORS LP (937K shares), STATE STREET CORP (780K shares), GEODE CAPITAL MANAGEMENT, LLC (656K shares), BESSEMER GROUP INC (576K shares), RENAISSANCE TECHNOLOGIES LLC (554K shares), RIVERBRIDGE PARTNERS LLC (518K shares), and AQR CAPITAL MANAGEMENT LLC (480K shares).
This table shows the top 578 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.